← Back to Clinical Trials
Recruiting NCT02831335

NCT02831335 Technical Development of Multi-Parametric Renocerebral MRI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02831335
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Aging
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2026-12-01
Primary Completion 2030-12-31

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
MRIMRIMRI

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2026-12-01 with a primary completion date of 2030-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and functional MRI methods along with a battery of cognitive tests.

Eligibility Criteria

Inclusion Criteria: 1. English-speaking as primary language 2. No hearing loss or uncorrected vision Exclusion Criteria: 1. Lacking capacity to consent 2. Having known history of cardiovascular diseases (e.g., clinical stroke) 3. Having acute and chronic obstructive pulmonary disease 4. Having known history of renal diseases (e.g., acute kidney injury) 5. Having known history of cognitive disorder or psychiatric illness 6. Having known history of chemical dependence (e.g., alcohol and narcotics) 7. Being treated with stimulant medications, anticonvulsants, antihypertensives or ß-adrenergic blockers

Contact & Investigator

Central Contact

Xiufeng Li, Ph.D.

✉ lixx1607@umn.edu

📞 6126258258

Principal Investigator

Xiufeng Li, Ph.D.

PRINCIPAL INVESTIGATOR

University of Minnesota

Frequently Asked Questions

Who can join the NCT02831335 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 80 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02831335 currently recruiting?

Yes, NCT02831335 is actively recruiting participants. Contact the research team at lixx1607@umn.edu for enrollment information.

Where is the NCT02831335 trial being conducted?

This trial is being conducted at Minneapolis, United States.

Who is sponsoring the NCT02831335 clinical trial?

NCT02831335 is sponsored by University of Minnesota. The principal investigator is Xiufeng Li, Ph.D. at University of Minnesota. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology